HomeNews & TopicsResearchReasons for cannabis use during pregnancy and lactation: a qualitative study

Reasons for cannabis use during pregnancy and lactation: a qualitative study

Published on

People who use cannabis during pregnancy and lactation choose it to manage pregnancy-related symptoms and pre-existing conditions, such as nausea and vomiting, mental health problems, insomnia and more, according to new research published in CMAJ (Canadian Medical Association Journal).

Cannabis use by pregnant and breastfeeding people appears to be increasing, although there is a lack of evidence on prevalence and the effects of cannabis on offspring. This study provides interesting insights into motivations and the changing nature of reasons for use during different stages of reproduction.

“Our findings have very little resonance with evidence on motivations for cannabis use identified in nonpregnant populations, suggesting that motivations for use during pregnancy and lactation are unique,” writes Dr. Meredith Vanstone, McMaster University, Hamilton, Ontario, with coauthors. “The reasons for use provided by our participants more closely match those identified in studies of medical cannabis use, such as for controlling pain, anxiety, depression, muscle spasms, nausea or appetite, and for sleep, with many using cannabis to manage multiple symptoms.”

The study included 52 people recruited from across Canada, of whom 51 were women and 1 identified as nonbinary. All had used cannabis before their pregnancy. At the time of the interview, 30 people were pregnant and the remaining 22 were breastfeeding. The reasons that participants gave for using cannabis changed when they became pregnant. Some people stopped out of fear of harm to the fetus when they found out they were pregnant. Other people stopped because of social stigma, guilt and health reasons. Those who kept using cannabis described their motivation as related to managing symptoms of pregnancy and conditions that pre-existed pregnancy. After they gave birth, their motivations for using cannabis changed, more closely resembling the reasons they supplied for using cannabis before becoming pregnant.

These findings have implications for clinical practice, including counselling of pregnant and lactating people on the potential harms of cannabis use and alternative approaches.

“I think it’s important for physicians to understand that people who use cannabis during pregnancy are often doing so because they perceive important benefits of cannabis for controlling a variety of symptoms. There’s an opportunity here for exploring the benefits that pregnant patients are getting from cannabis and helping them find alternatives that we know are safe for both mom and baby,” Dr. Vanstone concludes.

“Reasons for cannabis use during pregnancy and lactation: a qualitative study” is published December 20, 2021.

Latest articles

From injection to ingestion: Can yeast make vaccines more accessible?

HN Summary • Oral Yeast-Based Vaccines: Researchers, including Emilija Vasiliunaité at Vilnius University Life Sciences...

Smarter tissue and organ repair thanks to next-gen hydrogel

HN Summary • uOttawa multidisciplinary team has built new hydrogels from synthetic peptides that can...

The Cost of Silence: Why Black Youth Mental Health Can’t Wait

When we talk about mental health in Canada, the general numbers often hide a...

Iron deficiency anemia – demystifying a common, treatable and preventable public health problem

Over 830,000 Canadians have iron deficiency anemia (IDA),1 the most common cause of anemia.2...

More like this

A new home for Canada’s largest Cancer Research Tumour Bank

Decades of cancer research — and thousands of patient tumour samples — now have...

Equity-focused study on immigrant kidney disease risk

HN Summary • A new SHN-led study published in BMJ Open reveals significant disparities in...

Shorter duration of antimicrobial therapy in common infections

HN Summary • Growing evidence shows that shorter courses of antibiotics are just as effective...

Global clinical trial exploring potential treatment for sickle cell disease

HN Summary • SHN is leading a global clinical trial testing tebapivat, an investigational oral...

Lithium study yields insights in the fight against HIV

Study in human cells finds low-cost drug keeps virus dormant through an unexpected pathway,...

Gene mutation in blood-forming cells may improve cancer immunotherapy results

Researchers at UHN’s Princess Margaret Cancer Centre have found that inactivation of the TET2...